Cargando…
Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making
BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer deaths worldwide, seriously affecting human community health and care. Emerging evidence has shown that aberrant glycosylation is associated with tumor progression and metastasis. However...
Autores principales: | Shi, Yanlong, Wang, Yizhu, Yang, Rui, Zhang, Wenning, Zhang, Yu, Feng, Kun, Lv, Qingpeng, Niu, Kaiyi, Chen, Jiping, Li, Li, Zhang, Yewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807760/ https://www.ncbi.nlm.nih.gov/pubmed/36605944 http://dx.doi.org/10.3389/fendo.2022.1090324 |
Ejemplares similares
-
N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment
por: Shi, Yanlong, et al.
Publicado: (2023) -
Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms
por: Niu, Kaiyi, et al.
Publicado: (2023) -
Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy
por: Shi, Yanlong, et al.
Publicado: (2023) -
The impact of sex hormone concentrations on decision-making in females and males
por: Derntl, Birgit, et al.
Publicado: (2014) -
Shared Decision-Making in Growth Hormone Therapy—Implications for Patient Care
por: Acerini, Carlo L., et al.
Publicado: (2018)